WOBURN, Mass.–(BUSINESS WIRE)–Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced the appointment of Michael Campbell as Executive Vice President and Chief Financial Officer. He had served as interim Chief Financial Officer since April 13, 2022 … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related disorders, announced today that Ruoxi (Rosy) Hu, Ph.D., from Morningside Technology Advisory, LLC has been appointed to the company’s Board of Directors. Dr. Hu replaces Jay Galeota, who recently stepped down from the Board. … [Read more…]

MADISON, Wis.–(BUSINESS WIRE)–Navitus Health Solutions, an industry-disrupting pharmacy benefit manager (PBM) that’s committed to bringing humanity to pharmacy benefits management, released its 2021 Annual Drug Trend Report demonstrating pharmacy benefit cost savings for its customers and improved affordability for members. Navitus’ new report shows that new clients who moved to Navitus from another PBM in … [Read more…]

NEW YORK–(BUSINESS WIRE)–#MJFF—Koneksa, a healthcare technology company pioneering digital biomarkers, announced today that it has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) in collaboration with Northwestern University. The research study will evaluate a measurement concept that is designed to objectively quantify the severity of symptoms related to … [Read more…]

BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the company will participate in Cowen’s 7th Annual FutureHealth Conference, a virtual event taking place June 22 – June 23, 2022. Corey McCann, M.D., Ph.D., President and CEO, will participate in a panel discussion … [Read more…]

WALTHAM, Mass.–(BUSINESS WIRE)–Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced the appointment of Kelley Dealhoy as Senior Vice President and Chief Business Officer. Ms. Dealhoy brings 20 years of life science leadership experience to the role, and her responsibilities will include developing and leading the Company’s business development efforts as well as supporting corporate strategy initiatives. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Orthopedic Power Tools and Consumables Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030” report has been added to ResearchAndMarkets.com’s offering. Orthopedic Power Tools and Consumables Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, … [Read more…]

Pre-Clinical Research Could Lead to Rapid Development of Dopamine-Producing Neurons; Part of Company’s NIH-Funded Program Seeking Scalable Cell Replacement Therapy Approaches for Parkinson’s Disease Use of Non-Viral, Self-Amplifying RNA Enhanced and Lengthened Transcription Factor Expression, Driving the Signaling Required for Dopamine-Producing Neuron Development Findings Presented at 2022 International Society for Stem Cell Research Annual Meeting … [Read more…]

Highlights The C$2.9 billion transaction advances both LifeWorks and TELUS Health strategic plans to create the unparalleled leader in employee wellness The transaction has received the unanimous approval of LifeWorks’ Board of Directors and is subject to approval by LifeWorks shareholders LifeWorks shareholders will have option to receive C$33.00 per share in cash, TELUS shares … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Wrist Replacement Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030” report has been added to ResearchAndMarkets.com’s offering. The model discusses in detail the impact of COVID-19 on Wrist Replacement Devices market for the year 2020 and beyond. About 75% of the … [Read more…]